Insulet Valuation
| PODD Stock | USD 255.44 10.77 4.40% |
At this time, the firm appears to be undervalued. Insulet retains a regular Real Value of $275.56 per share. The prevalent price of the firm is $255.44. Our model calculates the value of Insulet from evaluating the firm fundamentals such as Return On Equity of 0.43, current valuation of 18.37 B, and Return On Asset of 0.068 as well as inspecting its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that Insulet's price fluctuation is very steady at this time. Calculation of the real value of Insulet is based on 3 months time horizon. Increasing Insulet's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Insulet stock is determined by what a typical buyer is willing to pay for full or partial control of Insulet. Since Insulet is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Insulet Stock. However, Insulet's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 255.44 | Real 275.56 | Hype 255.37 | Naive 248.67 |
The real value of Insulet Stock, also known as its intrinsic value, is the underlying worth of Insulet Company, which is reflected in its stock price. It is based on Insulet's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Insulet's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Insulet helps investors to forecast how Insulet stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Insulet more accurately as focusing exclusively on Insulet's fundamentals will not take into account other important factors: Insulet Total Value Analysis
Insulet is at this time forecasted to have valuation of 18.37 B with market capitalization of 17.94 B, debt of 83.8 M, and cash on hands of 708.6 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Insulet fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
18.37 B | 17.94 B | 83.8 M | 708.6 M |
Insulet Investor Information
About 100.0% of the company shares are owned by institutional investors. The company recorded earning per share (EPS) of 5.77. Insulet had not issued any dividends in recent years. Based on the key indicators related to Insulet's liquidity, profitability, solvency, and operating efficiency, Insulet is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April.Insulet Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Insulet has an asset utilization ratio of 67.09 percent. This indicates that the Company is making $0.67 for each dollar of assets. An increasing asset utilization means that Insulet is more efficient with each dollar of assets it utilizes for everyday operations.Insulet Ownership Allocation
The majority of Insulet outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Insulet to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Insulet. Please pay attention to any change in the institutional holdings of Insulet as this could imply that something significant has changed or is about to change at the company. On April 19, 2024, Senator Tina Smith of US Senate acquired $50k to $100k worth of Insulet's common stock.Insulet Profitability Analysis
The company reported the previous year's revenue of 2.07 B. Net Income was 418.3 M with profit before overhead, payroll, taxes, and interest of 1.45 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Insulet's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Insulet and how it compares across the competition.
About Insulet Valuation
The stock valuation mechanism determines Insulet's current worth on a weekly basis. Our valuation model uses a comparative analysis of Insulet. We calculate exposure to Insulet's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Insulet's related companies.Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts. Insulet Corp operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 2300 people.
Insulet Growth Indicators
Investing in growth stocks can be very risky. If the company such as Insulet does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 73.9 M | |
| Quarterly Earnings Growth Y O Y | -0.062 | |
| Forward Price Earnings | 60.9756 |
Complementary Tools for Insulet Stock analysis
When running Insulet's price analysis, check to measure Insulet's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Insulet is operating at the current time. Most of Insulet's value examination focuses on studying past and present price action to predict the probability of Insulet's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Insulet's price. Additionally, you may evaluate how the addition of Insulet to your portfolios can decrease your overall portfolio volatility.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |